The report on Anti-Obesity Prescription Drugs Market by drug class (orlistat, phentermine and topiramate, bupropion and naltrexone, lorcaserin, liraglutide), distribution channel (retail pharmacy, hospital pharmacy and online pharmacy), age group (pediatric and adult) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Anti-Obesity Prescription Drugs Market is projected to grow at a CAGR of 4.97% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
Obesity Management Market: Phentermine and Topiramate Expected to be the Second Most Lucrative Segment by Drug Type: Global Industry Analysis and Opportunity Assessment 2017-2027
The global Obesity Treatment Surgery Devices Market is highly fragmented due to the presence of a various large number of players which forms a competitive environment. The report entails all-inclusive information associated with the latest market updates such as new ideas, market size, opportunity, growth path and trends for the forecast period of 2019-2025 to gain competitive edge across the globe. This report also highlights various important strategic mergers and acquisitions, company overview, financial details, and the latest development undertaken.
The Global Obesity Surgery Devices Market Research Report 2017 provides a detailed Obesity Surgery Devices industry overview along with the analysis of industry’s gross margin, cost structure, consumption value and sale price. The key companies of the market, manufacturers, distributors along with the latest development trends and forecasts are detailed in the report.
Get a sample brochure @ http://tinyurl.com/gn984fc This report studies Anti-Obesity Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Get a sample brochure @ http://tinyurl.com/gn984fc This report studies Anti-Obesity Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Get a sample brochure @ http://tinyurl.com/gn984fc This report studies Anti-Obesity Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
The Anti-Obesity Drugs Industry 2015 report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.
Only one older generation drug with modest efficacy had been available until the recent arrival of two new therapies that could potentially change the prescribing landscape. Will these drugs make a significant impact on the Obesity market? Which drugs are used off-label for the treatment of obesity?
Complete report on Medical Devices market spread across 76 pages providing 4 company profiles with 2 tables and 48 charts is now available at http://www.marketreportsonline.com/580819.html.
Big Market Research “Weight Loss and Weight Management Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2020. Visit for more info @ http://www.bigmarketresearch.com/weight-loss-and-weight-management-mnm-market The global weight loss and weight management market is expected to reach $206.4 billion by 2019 from $148.1 billion in 2014, growing at a CAGR of 6.9% from 2014 to 2019. The weight loss and weight management market is categorized on the basis of diets, equipment, and services.
The increasing cases of coronary artery disease and diabetes coupled with growing obesity globally are driving the market growth. On top of that, growing awareness related to heart conditions, technological advancement in treatments, and rising numbers of hospitals and healthcare infrastructure around the globe have propelled the myocardial ischemia market expansion. Moreover, strong economic growth, disposable incomes of patients, and improved standard of living can fuel the market growth over the forecast period.
Global gene editing tools market is expected to register a healthy CAGR of 17.63% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the growing preferences in demands for personalized medicine.
Infinium Global Research has added a new report on Global Anti-Obesity Prescription Drugs Market. The report predicts the market size of Anti-Obesity Prescription Drugs is expected to reach XX billion by 2024.
The report on Compression Therapy Market by product(compression pump, compression bandage, compression stocking and compression tape), disease condition (lymphedema, VTE and others), technology(static, dynamic) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Compression Therapy Market is projected to grow at a CAGR between 5.0% to 5.5% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The report on Laparoscopic Devices Market by equipment (laparoscopes, energy systems, internal closure, trocars, insufflations, wound protectors, hand assist), application (general, colorectal surgeries, bariatric, gynecological, urological surgery), end user (hospitals, ambulatory surgical centers) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Laparoscopic Devices Market is projected to grow at a CAGR of 7.2% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The report on Metabolic Disorders Therapeutics Market by disease type (diabetes, obesity, hypercholesterolemia and lysosomal storage disease), product (metachromatic leukodystrophy, globoid leukodystrophy, hepatic encephalopathy and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Metabolic Disorders Therapeutics Market is projected to grow at a CAGR of 5.7% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
Obesity Treatment Market, By Procedure Type (Gastric Bypass, Gastric Banding, Non-Invasive Surgery, Sleeve Gastrectomy); By Products Type (Gastric Bands, Gastric Balloons, Stapling Devices, Gastric Electrical Stimulators); By Drug Type (Malabsorption & Satiety Drugs, Combination Drugs, Appetite Suppressants)]; and Geography - Trend, Analysis and Forecast
A recent report published by Precision Business Insights on Obesity Treatment Market provides in-depth analysis of segments and sub-segments in the global as well as regional.
The global antiobesity market is expected to grow from $1.46 billion in 2020 to $2.4 billion in 2021 at a compound annual growth rate (CAGR) of 64.4%. The market is expected to reach $5.42 billion in 2025 at a CAGR of 22.6%.
Major players in the Anti-obesity Drugs Market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and Pfizer Inc. Read More @ https://bit.ly/3t1IBZj
According to the Association for PET Obesity Prevention (APOP), in 2018, an estimated 60 percent of cats and 56 percent of dogs in the United States were overweight or obese. Previous studies by APOP have suggested that 25% of overweight dogs develop severe joint problems. Obesity is the leading cause of joint-related disorders in pets. This may develop arthritis and pain associated with hip dysplasia. These represents a lucrative opportunity for manufacturers of orthopedic veterinary implants.
The Global Fitness Equipment Market is anticipated to surge ahead with a CAGR of 3.95% during the forecast period of 2022 to 2028. Get a Free Sample Report.
This report studies Anti Obesity Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Pfizer Merck Roche GlaxoSmithKline AstraZeneca
Big Market Research present “Global Anti-Obesity Drugs Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-anti-obesity-drugs-2015-2019-market Obesity is a medical condition in which there is surplus accumulation of fat in the body. It is linked with increased illness risk, disability, and death. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure.
Rising prevalence of population with obesity and chronic diseases due to unhealthy lifestyle is key factor driving market growth whereas increasing awareness about consequences of increasing obesity and growing corporate wellness programs will also fuel market growth
The global obesity surgery device market is estimated at USD 1,432.4 million in 2014. It is likely to grow at a CAGR of 9.6% from 2014 to 2020 to reach USD 2,489.5 million in 2020.
The study examines market revenues/growth from 2005 to 2018 forecast, in-depth competitor profiles and rankings, obesity trends and the cost to employers, market structure/types of weight loss and wellness programs offered to employers on-site, and the effect of Obamacare. https://www.bharatbook.com/healthcare-market-research-reports-452256/worksite-weight-loss-programs-a-market-analysis.html
Surgical Generators Market: Growing Number of Office-based Surgical Procedures to Boost Revenue Growth: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
The Global and Chinese Abdominal Obesity Drug Industry, 20132023 Market Research Report is a professional and indepth study on the current state of the global Abdominal Obesity Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Abdominal Obesity Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
Saudi Arabia Wellness Market Outlook to 2020 - Changing Demographics and Prevalence in Lifestyle Diseases will drive the Market" provides a comprehensive analysis of Wellness market in Saudi Arabia. The report covers various aspects such as market size of wellness market, market segmentation by wellness products & Services, fitness centers market size, spa/salon centers market size, personal care products market size, skin care market size
Persistence Market Research Released New Market Report on “Global Market Study on Obesity Surgery Devices: Asia-Pacific to Witness Highest Growth by 2020” the global obesity surgery devices market was valued at USD 1,432.4 million in 2014 and is expected to grow at a CAGR of 9.6% from 2014 to 2020, to reach an estimated value of USD 2,489.5 million in 2020.
Laparoscopy is a minimally invasive operation in which abdominal or pelvic surgery is performed through a small incision. It has several advantages over laparotomy, which requires larger incisions. Laparoscopy uses TV images to examine and diagnose the condition of a disease or to carry out surgery. A rise in the obese population has resulted in laparoscopic surgeries being popularly used for weight reduction (bariatric surgeries). In-depth analysis of the global laparoscopy devices market focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities. Competitive landscape section focuses on key leaders within the global laparoscopy devices market and their major growth strategies. Detailed analysis of segments helps in understanding market dynamics and would be beneficial for market professionals.
More Information @ http://bit.ly/2rpFa3Q Sudden excessive intake or dose of polyglycitol can cause diarrhea and other gastrointestinal diseases such as bloating, flatulence, and other abdominal discomforts. Alternative sweetening options to avoid such diseases include agave, dates, brown rice syrup, and coconut sugar. This may be considered as a restraint for the polyglycitol market.
Patient temperature management systems helps in avoiding complications related to surgeries such as perioperative hypothermia and surgical site infection. Availability of technologically advanced products along with rising demand for surface cooling and warming systems will fuel patient temperature management market growth. It plays a significant role in cancer treatment as lower body temperature results in multiplication of cancerous cells. Hence, temperature warming systems is used along with chemo and radiation therapy during cancer treatment. The system helps averting occurrence of neurologic injury during cardiac surgery stimulating the business growth. As per American Heart Association 2017 data, around 92.1 million people in the U.S. are suffering from CVD and it is estimated that nearly 43.9% of total U.S. population will suffer from CVD till 2030.
Antidiabetics Market size was valued over USD 49.5 billion in 2016 and is expected to witness more than 10.5% CAGR from 2017 to 2024. Get more details @ https://goo.gl/UNqMWV
Persistence Market Research Released New Market Report on “Global Market Study on Obesity Surgery Devices: Asia-Pacific to Witness Highest Growth by 2020” the global obesity surgery devices market was valued at USD 1,432.4 million in 2014 and is expected to grow at a CAGR of 9.6% from 2014 to 2020, to reach an estimated value of USD 2,489.5 million in 2020.
Obesity is a major growing health concern around the world. In most markets, a person is considered obese if their Body Mass Index (BMI) exceeds 30 kilograms per square meter (kg/m2), calculated by dividing body mass in kilograms by height in meters squared.
Cheese Powder Market size may witness significant gains owing to strong application scope in convenience food and dairy products demand. Get more details @ https://goo.gl/j7KsFe
Global Slimming Devices Market is expected to rise from its initial estimated value of USD 8.8 billion in 2018 to an estimated value of USD 18.3 billion by 2026 registering a CAGR of 9.5%. The growth in this market is getting increased as there is rise in obese population.
Download Sample brochure@ http://tinyurl.com/goc3byx Marketintelreports, ‘Obesity - Pipeline Review, H2 2015’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Obesity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Obesity and special features on late-stage and discontinued projects.
Rising prevalence of population with obesity and chronic diseases due to unhealthy lifestyle is key factor driving market growth whereas increasing awareness about consequences of increasing obesity and growing corporate wellness programs will also fuel market growth.
Avail more information from Sample Brochure of report @ http://bit.ly/2cOPATy The Worldwide Mobility Scooter market research report covers the present scenario and the growth prospects of the Worldwide Mobility Scooter Market for the period 2015 – 2021. The report provides in-depth analysis of the market size and growth of the Worldwide Mobility Scooter market. This report also provides the detailed information and data analysis of the Worldwide Mobility scooter market about the leading market segments based on design and geographies. Read analysis @ http://bit.ly/2csetji
OA is a condition in which the cartilage, a material that cushions the joints, breaks down. This leads to stiffness, inflammation, pain, and loss of joint movement. The exact etiology of OA is not fully understood. Obesity, overuse of the joint, weak thigh muscles, aging, and genetics are some of the common risk factors of OA; OA symptoms usually develop progressively. At first, there may be stiffness that appears to be more a niggle than a medical concern. Treatment is given depending on the affected joint, including the hand, wrist, neck, back, knee, and hip, and involves medication and exercise. Get access to detailed report at: http://www.researchbeam.com/global-osteoarthritis-2015-2019-market
Increase in awareness related to health, rising obesity in the urban population and the diseases associated with obesity, increasing in deaths caused by obesity and increasing need for a healthy and environmentally friendly meat substitutes are key factors contributing to high CAGR of Plant-based Meat during forecast period.
This report offers a comprehensive analysis of the Global Diabetes Devices Market: Industry Analysis & Outlook (2017-2021). For more mail: vikas@konceptanalytics.com